Foundation Grants
Community Vital Signs
About Us
Recce Pharmaceuticals Continues Strategic Partnership with Murdoch Children'S Research Institute
Foundation: Pew Charitable Trusts
A synthetic drug being developed for the treatment of life-threatening infections has the potential to become the first new treatment for antibiotic-resistant superbugs in more than 50 years, the New York Times reports.
According to the Pew Charitable Trusts, the drug, called RECCE 327, is the only synthetic polymer and drug candidate in development that has been "approved by the FDA for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria, including their superbug forms."
It has also been designated a "Qualified Infectious Disease Product" under the Generating Antibiotic Initiatives Now (GAIN) Act and given 10 years of market exclusivity post approval by the FDA.
But it's not yet approved for use in humans.
"The threat of antibiotic resistance is greater now than ever, and commercial-academic partnerships are crucial to advance antibiotic discovery," Andrew Steer, theme director of infection, immunity, and global health at Murdoch Children's Research Institute in Australia, says in a press release.
"The synergy between our organizations will undoubtedly lead to ground-breaking discoveries that have the potential to transform the landscape of infectious disease treatment."
Recce Pharmaceuticals, which is based in Australia, says its synthetic polymer anti-infectives have the potential to
Read the Entire Article
Selected Foundation News
A customized collection of news from foundations from around the Web.
Atlanta Mayor Andre Dickens has released the 2024 Summer Youth Employment Program Report.The report celebrates the success of this year's program, which saw more than 5,700 young people hired across...more
Hackensack Meridian CDI Researcher Loudig Earns NJ R&D Council's Emerging Tech Award.Loudig's award was announced on the list of winners by the Research & Development Council of New Jersey on July...more
Student entrepreneurs showcase public health innovations at 2024 Pitch Competition.UNC Gillings School of Global Public Health will host the event.The event will take place at UNC-Gillings in...more
Health professionals urge the community to act and address the dangers of antimicrobial resistance.Wayne State University researchers remind our community to understand the growing issue of...more
Unlocking Global Health and Wellness with Innovative Hydration Technology: Can AmiLyfe's Breakthrough Be Better Than Water? Developed in collaboration with NASA and the University of Florida, Gatto...more
The All India Institute of Medical Sciences, New Delhi and the Indian Institute of Technology Delhi have launched a groundbreaking new collaboration.The three institutions will draw on their...more
Florida immigrants are fearful after Trump promises 'largest deportation program in history' Trump says he will use the military to enforce the mass deportation.The remark prompted the American Civil...more
"Taylor Made Freestyle" is no longer available on official platforms because Drake pulled the track.The Copyright Office's recent report on digital replicas also recognizes the importance of h See...more
School of Theatre and Dance joins West Virginia Public Theatre for "A Christmas Carol" Current Students | West Virginia University School of theatre and dance joins WVPT."AChristmas Carol" will be...more
The Mountaineer Marching Band will return to New York City for the 98th Annual Macy's Thanksgiving Day Parade on November 28.The parade received a record-breaking 28.5 million views last year.The...more
Social Entrepreneurship
Spotlight
Is Corporate Philanthropy Dead?
Senay Ataselim-Yilmaz, Chief Operating Officer, Turkish Philanthropy Funds, writes that philanthropy often solves the very problems that stems from market failure. Some social issues, however, cannot be tackled by questioning the return on investment.